These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9869185)

  • 1. Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy.
    Toepfer M; Rommel F; Sitter T; Spannagl M; Held E; Schramm W; Schiffl H
    Thromb Haemost; 1998 Dec; 80(6):1035-6. PubMed ID: 9869185
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does peroral administration of factor VIII induce oral tolerance in patients with acquired haemophilia A?
    Lindgren A; Wadenvik H; Tarkowski A; Tengborn L
    Thromb Haemost; 2000 Apr; 83(4):632-3. PubMed ID: 10780332
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
    Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
    Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
    Petrovic M; Derom E; Baele G
    Haematologica; 2000 Aug; 85(8):895-6. PubMed ID: 10942956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
    José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
    Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotypic regulation of anti-factor VIII antibodies.
    Kazatchkine MD; Lacroix-Desmazes S; Moreau A; Kaveri SV
    Haematologica; 2000 Oct; 85(10 Suppl):97-9. PubMed ID: 11187885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors to factor VIII:C in nonhemophiliacs.
    Milica CD; Gradimir JM; Nada S; Radoje CB
    Am J Hematol; 1996 May; 52(1):61. PubMed ID: 8638615
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor VIII Inhibitors. Natural autoantibodies and anti-idiotypes.
    Gilles JG; Vanzieleghem B; Saint-Remy JM
    Semin Thromb Hemost; 2000; 26(2):151-5. PubMed ID: 10919407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired factor VIII inhibitor.
    Simpson WG; Neefe J; Zang J; Drosick R; Kearns R
    J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antibodies to factor VIII.
    Lacroix-Desmazes S; Moreau A; Pashov A; Sooryanarayana ; Stahl D; Saint-Remy JM; Kaveri SV; Kazatchkine MD
    Semin Thromb Hemost; 2000; 26(2):157-65. PubMed ID: 10919408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of factor VIII inhibitors.
    Kasper CK
    Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factor VIII inhibitors--their characteristics and clinical significance].
    Dmoszyńska A; Kniaź M; Sokołowska B
    Pol Arch Med Wewn; 1987 Dec; 78(6):333-40. PubMed ID: 3152083
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of acquired factor VIII antibody by extracorporeal immunoadsorption.
    Négrier C; Dechavanne M; Alfonsi F; Tremisi PJ
    Acta Haematol; 1991; 85(2):107-10. PubMed ID: 1902613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb).
    Knöbl P; Derfler K; Korninger L; Kapiotis S; Jäger U; Maier-Dobersberger T; Hörl W; Lechner K; Pabinger I
    Thromb Haemost; 1995 Oct; 74(4):1035-8. PubMed ID: 8560408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired hemophilia a: a current review of autoantibody disease.
    Sborov DW; Rodgers GM
    Clin Adv Hematol Oncol; 2012 Jan; 10(1):19-27. PubMed ID: 22398803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.